Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development-Reference-Cited by-同舟云学术

Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development

Published:2018-10 Issue:10 Volume:59 Page:1842-1866
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Bialer Meir¹,Johannessen Svein I.²³,Koepp Matthias J.⁴,Levy René H.⁵,Perucca Emilio⁶⁷,Tomson Torbjörn⁸,White H. Steve⁹

Affiliation:

1. Faculty of Medicine School of Pharmacy and David R. Bloom Center for Pharmacy Institute for Drug Research Hebrew University of Jerusalem Jerusalem Israel

2. National Center for Epilepsy Sandvika Norway

3. Department of Pharmacology Oslo University Hospital Oslo Norway

4. Department of Clinical and Experimental Epilepsy University College London Institute of Neurology London United Kingdom

5. Department of Pharmaceutics and Neurological Surgery University of Washington Seattle Washington

6. Department of Internal Medicine and Therapeutics University of Pavia Pavia Italy

7. IRCCS Mondino Foundation Pavia Italy

8. Department of Clinical Neuroscience Karolinska Institute Stockholm Sweden

9. Department of Pharmacy School of Pharmacy University of Washington Seattle Washington

Funder

Zogenix

National Institutes of Health

U.S. Army Medical Research Institute of Chemical Defense

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.14555

Reference99 articles.

1. Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development

2. Swedish Orphan Biovitrum. Kineret. Summary of product characteristics. Available at:https://www.medicines.org.uk/emc/medicine/23104#PRODUCTINFO. Accessed January 18 2018.

3. The IL-1β system in epilepsy-associated malformations of cortical development

4. Inflammasome induction in Rasmussen’s encephalitis: cortical and associated white matter pathogenesis

5. Does the imbalance between agonistic and antagonistic IL‐1 play a role in progression of febrile convulsions?;Ozen F;Eur Rev Med Pharmacol Sci,2016

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). II. Drugs in more advanced clinical development;Epilepsia;2024-08-22

2. Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: A retrospective and observational real‐world study;Epilepsia Open;2024-08-14

3. Enhanced oral bioavailability of cannabidiol by flexible zein nanoparticles: in vitro and pharmacokinetic studies;Frontiers in Nutrition;2024-07-17

4. Cannabidiol-Based Prodrugs: Synthesis and Bioevaluation;ACS Medicinal Chemistry Letters;2024-01-16

5. Imperatorin interacts additively with novel antiseizure medications in the mouse maximal electroshock-induced seizure model: an isobolographic transformation;Pharmacological Reports;2023-11-28